Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000448998

Medchemexpress LLC FASN-IN-3 | 2097262-60-5 | 384.47 | 10 MG
SDP

Catalog No. 5000448998
Encompass_Preferred

FASN-IN-3 is a fatty acid synthase (FASN) inhibitor. It was extracted from patent US20170119786A1, compound 242A. In vitro studies showed that FASN-IN-3 treatment of PBMC reduces IL-1 beta secretion from LPS or LTA stimulation. For monocytes, it reduces IL-1 beta from LTA stimulation, with a slight reduction after LPS stimulation.

  • Inhibits fatty acid synthase (FASN)
  • Reduces IL-1 beta secretion from PBMC stimulated with LPS or LTA
  • Reduces IL-1 beta from monocyte LTA stimulation
  • Solid appearance, off-white to yellow color

Catalog No. 50-004-48998 Supplier Medchemexpress LLC Supplier No. HYU0043610MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

FASN-IN-3 is a fatty acid synthase (FASN) inhibitor. It was extracted from patent US20170119786A1, compound 242A. In vitro studies showed that FASN-IN-3 treatment of PBMC reduces IL-1 beta secretion from LPS or LTA stimulation. For monocytes, it reduces IL-1 beta from LTA stimulation, with a slight reduction after LPS stimulation.

  • Inhibits fatty acid synthase (FASN)
  • Reduces IL-1 beta secretion from PBMC stimulated with LPS or LTA
  • Reduces IL-1 beta from monocyte LTA stimulation
  • Solid appearance, off-white to yellow color

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.